newsfilter
← Latest News
GlobeNewswire·

Magenta Therapeutics to Explore Strategic Alternatives

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company focused on improving stem cell transplantation, today announced that it has completed a